Open Access. Powered by Scholars. Published by Universities.®
Physical Sciences and Mathematics Commons™
Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Physical Sciences and Mathematics
Nonnative Forest Insects And Pathogens In The United States: Impacts And Policy Options, Gary M. Lovett, Marissa Weiss, Andrew M. Liebhold, Thomas P. Holmes, Brian Leung, Kathy F. Lambert, David A. Orwig, Faith T. Campbell, Jonathan Rosenthal, Deborah G. Mccullough, Radka Wildova, Matthew P. Ayres
Nonnative Forest Insects And Pathogens In The United States: Impacts And Policy Options, Gary M. Lovett, Marissa Weiss, Andrew M. Liebhold, Thomas P. Holmes, Brian Leung, Kathy F. Lambert, David A. Orwig, Faith T. Campbell, Jonathan Rosenthal, Deborah G. Mccullough, Radka Wildova, Matthew P. Ayres
Dartmouth Scholarship
We review and synthesize information on invasions of nonnative forest insects and diseases in the United States, including their ecological and economic impacts, pathways of arrival, distribution within the United States, and policy options for reducing future invasions. Nonnative insects have accumulated in United States forests at a rate of ~2.5 per yr over the last 150 yr. Currently the two major pathways of introduction are importation of live plants and wood packing material such as pallets and crates. Introduced insects and diseases occur in forests and cities throughout the United States, and the problem is particularly severe in the …
Successful Mdr-Tb Treatment Regimens Including Amikacin Are Associated With High Rates Of Hearing Loss, Chawangwa Modongo, Rafal S. Sobota, Boikobo Kesenogile, Ronald Ncube
Successful Mdr-Tb Treatment Regimens Including Amikacin Are Associated With High Rates Of Hearing Loss, Chawangwa Modongo, Rafal S. Sobota, Boikobo Kesenogile, Ronald Ncube
Dartmouth Scholarship
Aminoglycosides are a critical component of multidrug-resistant tuberculosis (MDR-TB) treatment but data on their efficacy and adverse effects in Botswana is scarce. We determined the effect of amikacin on treatment outcomes and development of hearing loss in MDR-TB patients. Patients started on MDR-TB treatment between 2006 and 2012 were included. Multivariate analysis was used to determine the effect of amikacin on treatment outcomes and development of hearing loss.